FIELD: medicine and pharmaceuticals.
SUBSTANCE: group of inventions can be used to treat biotin-deficient conditions in children of the first year of life and older. A composition for the treatment of biotin-deficient conditions in children of the first year of life and older is proposed, containing biotin, vitamins B1, B2, B3, B5, B6, B9, a filler, which is a mixture of dextrose and maltodextrin in a ratio of 1:1 by weight, with the following the ratio of components in grams per 1,000 g of the following mixture: Biotin — 2.5–10; B3-Nicotinamide — 0.488; B5-Calcium pantothenate — 0.12; B6-pyridoxine hydrochloride — 0.05; B1-Thiamin mononitrate — 0.04; B2-Riboflavin — 0.045; B9-Folic acid — 0.0106; filler — the rest. A method for treating biotin-deficient conditions in children of the first year of life and older includes adding the specified composition to a food product suitable for children of the first year of life and older, and a single dose of biotin of 2.5–20 mg, and the daily dose reaching 100 mg/day.
EFFECT: invention makes it possible to effectively and safely treat biotin-deficient conditions in children of the first year of life and older, and the indicated agent has a high solubility, which makes it possible to add it to breast milk substitutes and complementary foods.
3 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING AND PREVENTING DYSMETABOLIC NEPHROPATHY IN CHILDREN ASSOCIATED WITH TOXIC ACTION OF CADMIUM, LEAD, CHROME AND PHENOL OF ANTHROPOGENIC ORIGIN | 2015 |
|
RU2598346C1 |
METHOD OF TREATMENT OF CHILDREN WITH DISMETABOLIC NEPHROPATHY FROM ECOLOGICALLY ADVERSE REGIONS | 1995 |
|
RU2131730C1 |
METHOD FOR TREATMENT AND PREVENTION OF GLOMERULAR AND TUBULOINTERSTITIAL KIDNEY DISEASE IN CHILDREN, ASSOCIATED WITH TOXIC EFFECT OF CADMIUM, LEAD, CHROMIUM AND PHENOL OF TECHNOGENIC ORIGIN | 2015 |
|
RU2580314C1 |
COMPOSITION OF PROTEIN-FREE FORMULA FOR DIET NUTRITION OF CHILDREN WITH HEREDITARY DISORDERS OF AMINO-ACID EXCHANGE | 2008 |
|
RU2361409C1 |
METHOD OF TREATING CONGENITAL STRUCTURAL MYOPATHIES AND CONGENITAL MUSCULAR DYSTROPHIES BY CORRECTION OF SECONDARY MITOCHONDRIAL CHANGES | 2008 |
|
RU2400221C2 |
DIETARY SUPPLEMENT (VERSIONS) | 2007 |
|
RU2352147C2 |
AGENT FOR TREATMENT OF PYLORIC CAMPILOBACTERIOSIS | 0 |
|
SU1836950A1 |
ADIPOSITY RISK REDUCTION | 2010 |
|
RU2559646C2 |
METHOD FOR TREATMENT OF HERPES HEPATITIS | 2009 |
|
RU2441646C2 |
PHARMACEUTICAL NEUROPROTECTIVE, ANTIOXIDANT, ANTIHYPOXIC, ANTIAPOPTOTIC AND MEMBRANE PROTECTIVE COMPOSITION AND METHOD OF TREATMENT | 2008 |
|
RU2385722C1 |
Authors
Dates
2023-05-05—Published
2023-03-18—Filed